Aerobic exercise helps to maintain cardiovascular health in part by mitigating age-induced arterial stiffening. However, the long-term effects of exercise regimens on aortic stiffness remain unknown, especially in the intimal extracellular matrix layer known as the subendothelial matrix. To examine how the stiffness of the subendothelial matrix changes following exercise cessation, mice were exposed to an 8 week swimming regimen followed by an 8 week sedentary rest period. Whole vessel and subendothelial matrix stiffness were measured after both the exercise and rest periods. After swimming, whole vessel and subendothelial matrix stiffness decreased, and after 8 weeks of rest, these values returned to baseline. Within the same time frame, the collagen content in the intima layer and the presence of advanced glycation end products (AGEs) in the whole vessel were also affected by the exercise and the rest periods. Overall, our data indicate that consistent exercise is necessary for maintaining compliance in the subendothelial matrix.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938067 | PMC |
| http://dx.doi.org/10.1115/1.4039579 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Endothelial YAP/TAZ activation promotes atherosclerosis in a mouse model of Hutchinson-Gilford progeria syndrome.
J Clin Invest
October 2024
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
Article Synopsis
- Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disorder linked to a mutation in the LMNA gene, leading to accelerated aging and early death from cardiovascular issues.
- Research using single-cell RNA sequencing on progerin-expressing mice revealed significant changes in endothelial cells, including alterations in gene expression, increased inflammation, and activation of a pathway (YAP/TAZ) related to mechanosensing.
- Targeting the YAP/TAZ pathway with a drug, verteporfin, reduced inflammation and atherosclerosis in the affected mice, suggesting potential new treatment options for HGPS-related vascular complications.
[Pathogenesis of Fuchs endothelial corneal dystrophy, the fibrillar layer and individualized treatment].
Ophthalmologie
October 2024
Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Köln, Deutschland.
Article Synopsis
- Fuchs endothelial corneal dystrophy (FECD) is a genetic and age-related disease leading to the loss of corneal endothelial cells, resulting in corneal swelling and vision issues.
- Advanced FECD often shows a fibrillar layer (FL) on the corneal surface, especially in the inferotemporal quadrant, which can be measured using specialized imaging techniques.
- Current treatments mainly involve corneal transplantation, particularly DMEK surgery, with new approaches like smaller grafts and advancements in imaging for better assessment and planning of surgeries.
Atherosclerosis on a Chip: A 3-Dimensional Microfluidic Model of Early Arterial Events in Human Plaques.
Arterioscler Thromb Vasc Biol
December 2024
Department of Nephrology and Hypertension, Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht University, the Netherlands (R.M., C.G.M.v.D., E.M.M., M.M.K., I.C., M.C.V., C.C.).
Article Synopsis
- - This study aimed to create a realistic 3D model of human atherosclerosis by coculturing different cell types, including smooth muscle cells and foam cells, to mimic a diseased blood vessel and study immune cell interactions under flow conditions.
- - Researchers developed a specialized coculture protocol using fluorescently labeled human cells and examined how these cells behaved in normal vs. atherosclerotic vessel environments over 24 hours of perfusion.
- - Results showed the model formed early atherosclerotic lesions, with distinct layers and foam cell accumulation, while circulating immune cells (THP-1 monocytes) exhibited movement into the vessel walls and responded to atherosclerosis-related signals.
Treatment with APAC, a dual antiplatelet anticoagulant heparin proteoglycan mimetic, limits early collar-induced carotid atherosclerotic plaque development in Apoe mice.
Atherosclerosis
October 2024
Research Program Unit in Systems Oncology, Medical Faculty, University of Helsinki, Helsinki, Finland; Aplagon Ltd, Helsinki, Finland; Coagulation Disorders Unit, Helsinki University Central Hospital, Helsinki, Finland.
Background And Aims: Mast cell-derived heparin proteoglycans (HEP-PG) can be mimicked by bioconjugates carrying antithrombotic and anti-inflammatory properties. The dual antiplatelet and anticoagulant (APAC) construct administered, either locally or intravenously (i.v.
View Article and Find Full Text PDFResponse to retention hypothesis as a source of targets for arterial wall-directed therapies to prevent atherosclerosis: A critical review.
Atherosclerosis
October 2024
School of Pharmacy, The University of Queensland, Brisbane, Queensland, 4102, Australia; Institute for Biomedicine and Glycomics, Griffith University, Nathan, Queensland, 4111, Australia; Discovery Biology, School of Environment and Science, Griffith University, Nathan, Queensland, 4111, Australia. Electronic address:
The subendothelial retention of circulating lipoproteins on extracellular matrix proteins and proteoglycans is one of the earliest events in the development of atherosclerosis. Multiple factors, including the size, type, composition, surrounding pH, and chemical modifications to lipoproteins, influence the electrostatic interactions between relevant moieties of the apolipoproteins on lipoproteins and the glycosaminoglycans of proteoglycans. The length and chemical composition of glycosaminoglycan chains attached to proteoglycan core proteins determine the extent of initial lipoprotein binding and retention in the artery wall.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!